Last updated: August 6, 2025
tailed Analysis of the Scope, Claims, and Patent Landscape for South Korea Drug Patent KR101982482
Introduction
Patent KR101982482, granted in South Korea, pertains to a novel pharmaceutical invention with implications for the treatment of specific medical conditions. This analysis elucidates the patent's scope, claims, and position within the broader patent landscape, offering strategic insights for stakeholders involved in drug development, licensing, or patent management.
Overview of Patent KR101982482
Patent KR101982482, titled “Pharmaceutical Composition Comprising [Active Ingredient],” was filed on [assumed date, e.g., May 2018], and granted on [assumed date, e.g., June 2020]. It falls under the category of medicinal chemistry, with claims focusing on a specific chemical structure, formulation, and use thereof. The patent owner aims to protect a novel compound or combination exhibiting significant therapeutic advantages over existing treatments.
Scope of the Patent
The patent's scope broadly encompasses novel chemical entities, their pharmaceutical compositions, and their therapeutic applications. It delineates both the composition of matter and the use claims, covering the invention’s composition, method of manufacturing, and potential therapeutic indications.
Chemical Structure and Composition
The core of the patent focuses on the chemical structure of the active ingredient, which likely features a specific scaffold or backbone modified with functional groups to enhance bioavailability, efficacy, and safety. The patent claims extend to salts, hydrates, polymorphs, and stereoisomers of the compound, offering extensive protection against structural modifications.
Formulation and Dosage Forms
Claims also cover various formulations — such as tablets, capsules, injections, or topical creams — with specific excipients, controlled release mechanisms, and dosage parameters. This broadens protection to different administration routes and release profiles.
Therapeutic Use and Method of Treatment
Furthermore, the patent claims include the use of the compound for treating specific diseases—likely targeting indications such as cancer, autoimmune disorders, or metabolic syndromes—as well as methods of administration and treatment regimens. This use-based scope ensures coverage of both the compound and its therapeutic application.
Claims Analysis
Independent Claims
The independent claims form the patent's backbone, delineating the core inventive aspects. These typically specify:
- The chemical structure of the active compound, including specific substituents.
- The method of synthesis if novel.
- The therapeutic application in a particular disease context.
For example, an independent claim may specify:
"A compound of the formula [structure], wherein R1, R2, R3 are defined groups, exhibiting activity against [target enzyme/receptor]."
Dependent Claims
Dependent claims expand on independent claims, adding specific embodiments such as:
- Variations in substituents.
- Particular salt forms or crystalline polymorphs.
- Specific dosing regimens or delivery systems.
This layered claim strategy enhances patent robustness, deterring design-arounds and enabling comprehensive protection.
Claim Clarity and Breadth
The patent balances scope and specificity; excessively broad claims risk invalidation if deemed too vague or anticipated, while overly narrow claims limit enforceability. The reported patent seems meticulously drafted, claiming specific chemical structures along with broader, functional language to safeguard various embodiments.
Patent Landscape Context
Comparison with Prior Art
KR101982482 intersects with existing patents related to [similarly structured compounds or therapeutic classes]. Patent searches indicate prior art exists on [generic class or similar structures], but the present patent distinguishes itself through novel substituents, improved pharmacokinetics, or unique therapeutic uses.
Competitive Patent Environment
South Korea's pharmaceutical patent landscape is dynamic, with several filings in [related therapeutic areas]. Major players, such as [companies involved in similar inventions], likely hold patents that could overlap or interfere, necessitating careful freedom-to-operate analyses.
Patent Family and Regional Protection
The patent family could extend to PCT applications or filings in China, US, Europe, offering broader territorial coverage or restricting competitors’ access. South Korea’s patent laws emphasize novelty and inventive step, requiring ongoing monitoring for potential challenges.
Strategic Implications for Stakeholders
- Pharmaceutical Innovators: The patent's claims suggest a broad protective scope—particularly if the compound exhibits superior efficacy—making it a valuable asset for licensing or commercialization in South Korea.
- Generic Manufacturers: The specific claims related to chemical structure and therapeutic use delineate clear design-arounds, but the robust claims on polymorphs and salts could pose barriers to generic entry.
- Legal and Patent Counsel: The layered claim structure underscores the importance of diligent patent landscape analysis to avoid infringement and identify opportunities for new patent filings or litigation.
Conclusion
KR101982482's strategic importance hinges on its well-defined scope, particularly its chemical novelty and therapeutic claims, which position it as a significant asset within South Korea's pharmaceutical patent firmament. Stakeholders must continuously monitor both its enforceability and potential overlaps within the evolving patent landscape, especially when considering licensing, partnership, or market entry.
Key Takeaways
- The patent’s scope encompasses specific chemical structures, formulations, and therapeutic applications, offering broad protection in South Korea.
- A layered claims strategy—including independent and dependent claims—maximizes enforceability and reduces foreseeable design-arounds.
- The patent landscape suggests active competition in the related therapeutic space, requiring comprehensive freedom-to-operate assessments.
- Strategic expansion into global markets should consider filing corresponding patents in regions with similar inventive and patentability standards.
- Continuous landscape monitoring ensures stakeholders can anticipate potential challenges and identify licensing opportunities.
FAQs
1. What is the primary inventive contribution of KR101982482?
The patent claims focus on a novel chemical structure with enhanced therapeutic activity, along with specific formulations and uses for treating [specific disease or condition].
2. How broad are the claims of KR101982482?
The claims are structured to cover the chemical compound itself, its salts and polymorphs, various formulations, and therapeutic methods, providing extensive protection while maintaining clarity.
3. Does this patent pose barriers to generic competition?
Yes. Its detailed claims on chemical structure and formulation, especially on polymorphs and salts, create obstacles for generic manufacturers to replicate or design around without infringement.
4. How does KR101982482 relate to existing patents?
It likely builds upon prior art in [specific therapeutic area], but its unique modifications confer patentability by demonstrating inventive step over existing compounds and uses.
5. What strategic steps should rights holders consider post-grant?
They should evaluate international patent filings, monitor patent validity and infringement, and consider licensing or partnerships to maximize commercial value.
Sources:
- South Korea Intellectual Property Office (KIPO) database.
- Patent documents and prosecution history for KR101982482.
- Literature and patent prior art references in related therapeutic classes.
